Press Releases
Click on recent press releases from NMT2 and its distribution partner HeartStitch.

NobleStitch™ EL Closure Data Compared to Published PFO Clinical Trials “RESPECT” and “CLOSURE” in New England Journal of Medicine

NobleStitch™ EL Closure Data Compared to Published PFO Clinical Trials “RESPECT” and “CLOSURE” in New England Journal of Medicine
Presents Progressive Multi Center Data at Three Consecutive Clinical Congresses
Dr. Michael Mullen Presents Multi-Center Clinical Data of More Than 100 NobleStitch™ EL Patients at Major U.S. Cardiac Congress
Prof Giulio Speciale and Prof Achille Gaspardone Present the First Ever Italian Live Case of the NobleStitch™ EL Performed at the 2016 GISE Structural Heart Congress in Genova, Italy
Successful PFO Closures Completed in Multiple Countries Over One Week Using NobleStitch™ EL Suture Based System
Prof. Nobles Presented Revolutionary First in Man Clinical Case of ASD (Atrial Septal Defect) Closure and ASA (Atrial Septal Aneurysm) Repair at Structural Heart Conference
Successful Multi-Center Data for NobleStitch™ EL Presented at Structural Heart Conference Highlights the Benefits of Device-less PFO Closure
Prof Horst Sievert Opens the 2016 CSI Structural Heart Congress by Performing a Live PFO Closure Case Using Noblestitch™ EL
HeartStitch Expanding Clinical Data Across The Globe

Prof. Horst Sievert Performs Multiple Closures

​Nobles Medical Technologies II, Inc. Launches NobleStitch™ EL Sales in Germany With Five Successful Cases

​Nobles Medical Technologies II Receives Allowance of Its Groundbreaking Patent for Next-Generation Suturing Device

​NobleStitch™ EL Sales Launch in Italy

Nobles Medical Technologies II Receives Significant Japanese Patent for "Suturing Devices and Methods for Closing a Patent Foramen Ovale" Using Its NobleStitch™ Technology

​First in Man -- First Ever Percutaneous Atrial Septal Defect (ASD) Closure and Atrial Septal Aneurysm (ASA) Repair Performed Without an Implantable Device Using the NobleStitch EL

​NobleStitch™ EL Receives Approval in Kazakhstan to Treat PFO and to Suture Cardiac Structures

​Top Swedish Heart Center Confirms PFO-Closure Benefits of NobleStitch™ EL Among Widening Patient Population

​Nobles Medical Technologies II Board Strengthened by Union Capital Group SA's Antoine Felicelli

​NMT II Live PFO Closure Creates Stir at Global Meeting of Cardiologists

​Nobles Medical Technologies II's NobleStitch EL Now the Primary Choice for PFO Closure at Top Swedish Heart Centre After Successful Annual Follow-Up on Initial Clinical Results

​Nobles Medical Technologies II Enrolls Patients In US Clinical Study of NOBLESTITCH PFO Suture Closure System.

​Nobles Medical Technologies II Announces Positive Results for the 1-Year Follow Up of Patients Treated With the NobleStitch EL PFO Closure System Highlighted at the 2014

​Nobles Medical Technologies II Treats First Patient in Sweden with NobleStitch EL PFO Closure Device

​First US Patient with NobleStitch EL PFO Closure Device

​Nobles Medical Technologies II Receives Japanese Patent for “Suturing Devices and Methods for Closing a Patent Foramen Ovale”

​Nobles Medical Technologies II's Launches Sales in Sweden for its Minimally Invasive NobleStitch® EL System for PFO Closure

​Nobles Medical Technologies II, Inc. Receives Recertification of ISO13485 and EN-ISO 14971

​Nobles Medical Has Perfect FDA Audit

​Nobles Medical Technologies II Receives US Patent for “Suturing and Method” for its NobleStitch Technology

​Nobles Medical Technologies II's NobleStitch EL Receives Strong Reviews from Physicians at Congenital & Structural Interventions Congress (CSI) in Frankfurt


Copyright © 2018